PROFILE |
 |
bioMérieux-Pierre Fabre sweats the small stuff. The company was formed by the merger of microbiology leader bioMérieux Alliance, maker of "in vitro" diagnostics with a focus on infectious diseases; and Pierre Fabre, a leading pharmaceutical and dermo-cosmetics maker. The company focuses on various therapeutic areas, including dermo-cosmetics, clinical diagnostics, pharmaceuticals, and immunotherapy. The company sells its products in more than 120 countries; about half of its sales come from abroad. Ownership of the new company is split evenly between the two founding groups, which were both largely controlled by founders Alain Mérieux and Pierre Fabre.
COMPETITION |
 |
Becton, Dickinson and Company (BDX)
Cell Genesys, Inc. (CEGE)
Diagnostic Products Corporation (DP)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: September
2000 Sales (mil.): 549.50
1-Yr. Sales Growth: 0.5%
Employees: 3,703
Revenue per employee: $148,393.19
KEY PEOPLE |
 |
Jean-Luc Bélingard
CEO
Philippe Villet
CFO
CONTACT INFO |
 |
376 Chemin Orme
69280 Marcy l'Étoile, France
Phone: 33-478-87-2000
Fax: 33-478-87-2128
Online: Web Site
|